Sartorius has launched the modular Eveo Cell Therapy Platform, an integrated system for the production and quality control (QC) of autologous cell therapies designed to address structural manufacturing bottlenecks that limit scalability and patient access to transformative treatments. “Cell therapies are redefining medical possibilities. Yet, they remain accessible to only a small share of patients because manufacturing is complex, capacity-constrained and therefore expensive. With our integr...